ARTICLE | Finance

Venture and Hedge Fund Tracks

Biotech investor, banker and analyst personnel changes

September 20, 2010 7:00 AM UTC

Vince Burgess, Peter Thompson and Joseph Zakrewski joined OrbiMed as venture partners, while Alexander Cooper joined as general counsel. Burgess was group president of advanced imaging systems at diagnostics company Volcano Corp. Thompson co-founded infectious disease company Trubion Pharmaceuticals Inc. (NASDAQ:TRBN) and was its chairman and CEO. Zakrzewski was president and CEO of biomanufacturing play Xcellerex Inc. Cooper was counsel for the asset management business at Goldman Sachs...